Detection of local recurrence following breast-conserving treatment in young women with early breast cancer: Optimization of long-term follow-up strategies

Breast

Volumn 22, Issue 3, 2013, Pages 351-356

  van der Sangen, Maurice J C ^a   Scheepers, Sanne W M ^b   Poortmans, Philip M P ^c   Luiten, Ernest J T ^d   Nieuwenhuijzen, Grard A P ^a   Voogd, Adri C ^e,f  

^a CATHARINA HOSPITAL   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Institute Verbeeten   (Netherlands)

^d AMPHIA HOSPITAL   (Netherlands)

^e Eindhoven Cancer Registry   (Netherlands)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Breast carcinoma; Breast conservation; Local recurrence; Radiotherapy; Young women

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RECURRENCE; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NETHERLANDS; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 84877129481     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2012.08.006     Document Type: Article

References (27)

1. DeSantis C., Siegel R., Bandi P., Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin 2011, 61:408-418.
2. van der Sangen M., van de Wiel F., Poortmans P., Tjan-Heijnen V., Nieuwenhuijzen G., Roumen R., et al. Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years. Breast Cancer Res Treat 2011, 127:207-215.
3. van Dongen J.A., Voogd A.C., Fentiman I.S., Legrand C., Sylvester R.J., Tong D., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial. J Natl Cancer Inst 2000, 92:1143-1150.
4. Fisher B., Anderson S., Bryant J., Margolese R.G., Deutsch M., Fisher E.R., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241.
5. van der Leest M., Evers L., van der Sangen M.J.C., Poortmans P.M., van de Poll-Franse L.V., Vulto A.J., et al. The safety of breast-conserving therapy in patients with breast cancer aged ≤40 years. Cancer 2007, 109:1957-1964.
6. de Bock G.H., van der Hage J.A., Putter H., Bonnema J., Bartelink H., van de Velde C.J. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European organisation for research and treatment of cancer studies. Eur J Cancer 2006, 42:351-356.
7. Anders C.K., Johnson R., Litton J., Phillips M., Bleyer A. Breast cancer before age 40 years. Semin Oncol 2009, 36:237-249.
8. Voogd A.C., Nielsen M., Peterse J.L., Blichert-Toft M., Bartelink H., Overgaard M., et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 2001, 19:1688-1697.
9. Poortmans P., Aznar M., Bartelink H. Quality indicators for breast cancer: revisiting historical evidence in the context of technology changes. Semin Radiat Oncol 2012, 22:29-39.
10. Montgomery D.A., Krupa K., Cooke T.G. Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer 2007, 97:1632-1641.
11. Lu W., Jansen L., Post W., Bonnema J., Van de Velde J., De Bock G. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 2009, 114:403-412.
12. Biglia N., Bounous V.E., Martincich L., Panuccio E., Liberale V., Ottino L., et al. Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast. Eur J Surg Oncol 2011, 37:199-204.
13. van der Sangen M.J.C., van de Poll-Franse L.V., Roumen R.M.H., Rutten H.J.T., Coebergh J.W.W., Vreugdenhil G., et al. The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. Eur J Surg Oncol 2006, 32:34-38.
14. Houssami N., Abraham L.A., Miglioretti D.L., Sickles E.A., Kerlikowske K., Buist D.S., et al. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA 2011, 305:790-799.
15. Schelfout K., Van Goethem M., Kersschot E., Colpaert C., Schelfhout A.M., Leyman P., et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 2004, 30:501-507.
16. Ternier F., Houvenaeghel G., Lecrivain F., Brigand B., Margain D., Brunelle S., et al. Computed tomography in suspected local breast cancer recurrence. Breast Cancer Res Treat 2006, 100:247-254.
17. Belli P., Costantini M., Romani M., Marano P., Pastore G. Magnetic resonance imaging in breast cancer recurrence. Breast Cancer Res Treat 2002, 73:223-235.
18. Li J., Dershaw D.D., Lee C.F., Joo S., Morris E.A. Breast MRI after conservation therapy: usual findings in routine follow-up examinations. Am J Roentgenol 2010, 195:799-807.
19. Hwang N., Schiller D., Crystal P., Maki E., McCready D. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann Surg Oncol 2009, 16:3000-3009.
20. Punglia R.S., Hassett M.J. Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors. J Clin Oncol 2010, 28:4108-4110.
21. Timmers J.M., den Heeten G.J., Adang E.M., Otten J.D., Verbeek A.L., Broeders M.J. Dutch digital breast cancer screening: implications for breast cancer care. Eur J Public Health 2011, [Epub ahead of print].
22. Morrow M., Waters J., Morris E. MRI for breast cancer screening, diagnosis, and treatment. Lancet 2011, 378:1804-1811.
23. de Sanjosé S., Léoné M., Bérez V., Izquierdo A., Font R., Brunet J.M., et al. Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study. Int J Cancer 2003, 106:588-593.
24. Pierce L.J., Levin A.M., Rebbeck T.R., Ben-David M.A., Friedman E., Solin L.J., et al. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol 2006, 24:2437-2443.
25. Grogan M., Rangan A., Gebski V., Boyages J. The value of follow-up of patients with early breast cancer treated with conservative surgery and radiation therapy. Breast 2002, 11:163-169.
26. Early and locally advanced breast cancer. Diagnosis and treatment February 2009, NICE clinical guideline 80 developed by the national collaborating centre for cancer issue date. http://www.nice.org.uk/nicemedia/pdf/CG80NICEGuideline.pdf.
27. Kimman M.L., Voogd A.C., Dirksen C.D., Falger P., Hupperets P., Keymeulen K., et al. Follow-up after curative treatment for breast cancer: why do we still adhere to frequent outpatient clinic visits?. Eur J Cancer 2007, 43:647-653.